Lupus a tough disease to spot, treat
(HealthDay)—Lupus is difficult to diagnose and treat, but scientists are working to learn more about its genetic causes and to develop better treatments.
May 30, 2016
0
90
(HealthDay)—Lupus is difficult to diagnose and treat, but scientists are working to learn more about its genetic causes and to develop better treatments.
May 30, 2016
0
90
(HealthDay)—A case of simultaneous diagnosis of systemic lupus erythematous (SLE) and pheochromocytoma, with disappearance of SLE after pheochromocytoma treatment, is described in a letter to the editor published online ...
May 17, 2016
0
3
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have identified an enzyme that is significantly elevated in mouse models of systemic lupus erythematosus and in blood samples of patients with lupus. Published online ...
May 16, 2016
0
385
Researchers at Monash University are leading the world's largest study to describe lupus patients and disease characteristics, bringing treat-to-target options for lupus a step closer.
May 10, 2016
0
14
(HealthDay)—Neither the American College of Rheumatology (ACR) nor the Systemic Lupus International Collaborating Clinics (SLICC) criteria distinguishes patients with subacute cutaneous lupus erythematosus (SCLE) with major ...
Apr 27, 2016
0
1
Researchers at the Baylor Institute for Immunology Research have discovered that the neutrophils of systemic lupus erythematosus (SLE) patients release oxidized DNA from their mitochondria that can stimulate an unwanted immune ...
Apr 18, 2016
0
14
A signaling molecule called interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients. The finding could lead to new treatments for the chronic autoimmune disease, said researchers ...
Apr 12, 2016
0
18
(HealthDay)—Severe preeclampsia (S-PEecl), but not non-severe preeclampsia (NS-PEecl), is associated with antiβ2GP1 immunoglobulin (Ig)G, according to a study published online Jan. 18 in the Journal of Thrombosis and Haemostasis.
Jan 26, 2016
0
2
Lupuzor may become the first specific and non-immunosuppressant therapy for lupus, a disabling autoimmune disease that is currently incurable. Discovered by Sylviane Muller's team in the CNRS Immunopathologie et Chimie Thérapeutique ...
Dec 15, 2015
0
34
For years, biomedical researchers have suspected that a specific set of immune cells are responsible for causing disease in lupus patients, but until now they haven't known for sure one way or the other.
Dec 7, 2015
0
62